http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MY-171497-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5df91b83742bcb8697bc96f405f4b8e8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04
filingDate 2013-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fe9358aeb6f828e3958ed66d665cda9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d0122060d119d5049e5a3951b0c0254
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5b6c1e846ef64c53e0c576acf6e2b3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_252eb98d7ac07a90b7eeb13edffe914a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adbc9dc7f71b72d6ef0173b75ac8044b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b0bf13a045c69a3e9c7faa39478ca15
publicationDate 2019-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MY-171497-A
titleOfInvention Crystalline forms of dihydropyrimidine derivatives
abstract The present invention relates to crystalline forms of dihydropyrimidine derivatives, and pharmaceutical compositions comprising the crystalline forms disclosed herein, which may be used for preventing, managing, treating or lessening the severity of a viral disease in a patient, especially hepatitis B infection or a disease caused by hepatitis B infection.
priorityDate 2012-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414854551
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1056

Total number of triples: 22.